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Abstract
Maternal exposure to stress during pregnancy is associated with significant alterations in offspring neurodevelopment and
elevated maternal glucocorticoids likely play a central role in mediating these effects. Placental 11b-hydroxysteroid
dehydrogenase type 2 (HSD11B2) buffers the impact of maternal glucocorticoid exposure by converting cortisol/
corticosterone into inactive metabolites. However, previous studies indicate that maternal adversity during the prenatal
period can lead to a down-regulation of this enzyme. In the current study, we examined the impact of prenatal stress
(chronic restraint stress during gestational days 14–20) in Long Evans rats on HSD11B2 mRNA in the placenta and fetal brain
(E20) and assessed the role of epigenetic mechanisms in these stress-induced effects. In the placenta, prenatal stress was
associated with a significant decrease in HSD11B2 mRNA, increased mRNA levels of the DNA methyltransferase DNMT3a, and
increased DNA methylation at specific CpG sites within the HSD11B2 gene promoter. Within the fetal hypothalamus, though
we find no stress-induced effects on HSD11B2 mRNA levels, prenatal stress induced decreased CpG methylation within the
HSD11B2 promoter and increased methylation at sites within exon 1. Within the fetal cortex, HSD11B2 mRNA and DNA
methylation levels were not altered by prenatal stress, though we did find stress-induced elevations in DNMT1 mRNA in this
brain region. Within individuals, we identified CpG sites within the HSD11B2 gene promoter and exon 1 at which DNA
methylation levels were highly correlated between the placenta and fetal cortex. Overall, our findings implicate DNA
methylation as a mechanism by which prenatal stress alters HSD11B2 gene expression. These findings highlight the tissue
specificity of epigenetic effects, but also raise the intriguing possibility of using the epigenetic status of placenta to predict
corresponding changes in the brain.
Citation: Jensen Pen ˜a C, Monk C, Champagne FA (2012) Epigenetic Effects of Prenatal Stress on 11b-Hydroxysteroid Dehydrogenase-2 in the Placenta and Fetal
Brain. PLoS ONE 7(6): e39791. doi:10.1371/journal.pone.0039791
Editor: Kang Sun, Fudan University, China
Received February 9, 2012; Accepted May 31, 2012; Published June 26, 2012
Copyright:  2012 Jensen Pen ˜a et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by Grants DP2OD001674 from the Office of the Director, National Institutes of Health and 1R01MH092580-01A1 from the
National Institutes of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: fac2105@columbia.edu
Introduction
In humans, the experience of stress during pregnancy is
associated with increased risk of preterm birth, reduced birth
weight, and smaller head circumference [1–3] and has been
implicated in the heightened risk of metabolic and psychiatric
disorders [4–7]. The long-term consequences of maternal stress
during gestation for offspring neurobiological and physiological
functioning have likewise been demonstrated in laboratory studies
using rodents [8–11], suggesting a causal link between this form of
prenatal adversity and various developmental outcomes. Though
there may be multiple pathways through which maternal stress
during pregnancy shapes offspring development, stress-induced
elevations in maternal glucocorticoids have emerged as a primary
mechanism of prenatal stress effects [12], supported by studies in
rats in which the effects of prenatal stress are prevented amongst
adrenalectomized females [13].
In mammals, the placenta serves as a critical interface between
maternal and fetal physiology and forms a barrier to maternal
glucocorticoids [14,15]. Human self-reports of stress during
pregnancy are associated with increased circulating cortisol, but
only 10–20% of maternal cortisol passes to the fetus [16,17]. This
barrier function of the placenta is achieved through the actions of
the enzyme 11b-hydroxysteroid dehydrogenase type 2 (11ß–
HSD2), which converts the glucocorticoids cortisol/corticosterone
into the inactive metabolites cortisone/11b-dehydrocorticoster-
one, thus preventing the activation of glucocorticoid receptors
[14]. In contrast, the enzyme 11ß–HSD1 converts inactive
glucocorticoids to cortisol/corticosterone [18,19]. Targeted gene
deletion and pharmacological studies suggest a functional conse-
quence of 11ß–HSD for the development of the hypothalamic-
pituitary adrenal (HPA) response to stress. In mice, mutation of the
HSD11B2 gene leads to hypertension, excess mineralocorticoid
activity, and increased anxiety-like behavior in adulthood [20]
whereas HSD11B1 mutation leads to attenuated negative-feedback
of the HPA response to stress and improved cognitive performance
in aging [21]. Pharmacological inhibition of 11ß–HSD2 during
pregnancy or administration of dexamethasone, a synthetic
glucocorticoid that is not metabolized by 11ß–HSD2, leads to
molecular and neurobiological changes within the HPA axis
associated with increased stress responsivity and anxiety-like
behavior in adulthood [22,23]. These glucocorticoid programming
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betamethasone exposure or inhibition of 11ß–HSD2 through
elevated glycyrrhizin consumption during pregnancy [24,25].
These studies suggest that the regulation of placental 11ß–HSD2
levels may be a mechanistic link between the experience of
maternal gestational stress and long-term health outcomes in
offspring.
There is increasing evidence that maternal adversity during
pregnancy may lead to a down-regulation of 11ß–HSD2. In
rats, chronic restraint stress during gestational days 11–20
(equivalent to the 2
nd–3
rd trimester of human pregnancy) was
found to decrease placental 11ß–HSD2 enzymatic activity and
decrease mRNA levels of this gene [26]. Similarly, rat dams
that are food restricted from gestational days 10–20, a manip-
ulation that increases maternal plasma corticosterone and
induces similar phenotypes to those observed following prenatal
stress, have reduced placental protein levels of 11ß–HSD2
[27,28]. In humans, heightened maternal anxiety (assessed just
prior to parturition) was found to be negatively correlated with
placental HSD11B2 mRNA levels [29]. Reduced placental
HSD11B2 mRNA levels have also been found associated with
intrauterine growth retardation and pre-term birth [30],
suggesting that the transcriptional activity of this enzyme may
be predicted by maternal adversity and predictive of high risk
birth outcomes.
Regulation of gene expression through epigenetic mechanisms
– factors that alter gene transcription without altering DNA
sequence - is being increasingly explored within the context of
environmentally-induced changes in neurobiology, metabolism,
and disease risk [31–33]. Epigenetic changes involving DNA
methylation (at cytosine-guanine sequences – CpG sites), post-
translational modification of histone proteins, and microRNAs
can have dynamic effects on gene expression and may also
account for the stability of experience-dependent effects on
transcription [34–38]. Epigenetic dysregulation has been asso-
ciated with prenatal intrauterine growth restriction [39] and
disease in both humans and rodents [39–41]. Moreover, there is
increasing evidence that maternal adversity during gestation can
induce epigenetic changes in placenta and fetal tissues that may
account for the heightened HPA reactivity amongst offspring
[9].
In the current study, we examined the impact of gestational
maternal stress in pregnant rats on the transcription and DNA
methylation of the HSD11B2 gene to determine whether
epigenetic factors may account for the down-regulation of
placental HSD11B2 function in response to stress. An important
consideration in studies of environmental-induced epigenetic
effects for which there has been limited empirical investigation,
is tissue specificity, and here we compared the impact of
gestational maternal stress on CpG methylation in placenta as
well as fetal hypothalamus and cortex. Moreover, we explored
the potential role of the DNA methyltransferases DNMT1 and
DNMT3a – enzymes that promote DNA methylation [42,43] –
in these tissues, to determine the possible mechanistic pathways
through which stress-induced epigenetic variation is achieved.
Finally, we also assessed the feasibility of using placental
epigenetic variation in the HSD11B2 gene to predict DNA
methylation levels of this gene in the fetal hypothalamus and
cortex. This study provides new insight into the molecular basis
of the effects of maternal adversity and highlights issues that are
critical for the study of epigenetic effects and the translation of
epigenetic analysis to studies of human prenatal exposures.
Methods
Animals & Husbandry
16 female and 8 male Long Evans rats (purchased from Charles
River) were maintained on a 12:12 hour light-dark schedule with
white lights on at 0800 h and off at 2000 h and housed 2 per cage
(same-sex) in 26650622 cm polycarbonate cages in the animal
facility at the Department of Psychology, Columbia University.
Food and water were available ad libitum and replenished daily by
animal care staff at 0900. Animals were habituated to the facility
for 2 weeks prior to mating. Pair-housed virgin females were
mated for one week. Timing of the pregnancy was confirmed by
the presence of a vaginal plug (designated as gestational day 0). All
procedures were performed in accordance with guidelines of the
NIH regarding the Guide for the Care and Use of Laboratory
Animals and with the approval of the Institutional Animal Care
and Use Committee (IACUC) at Columbia University.
Gestational Stress
Within the sample of 16 mated females, 12 females became
pregnant following the 1-week mating period. At gestational day
14, all pregnant females were singly-housed and assigned to either
non-stress (control, n=6) or stress (n=6) treatment conditions.
Control females were left undisturbed throughout gestational days
14–20. Stress females were exposed to restraint stress, through
placement in a 19629612 cm cage (which prevented vertical and
horizontal movement) for 1-hour/day from gestational days 14–
20. The timing of stress exposure was randomized to prevent
habituation. At gestational day 20, pregnant dams were sacrificed
1 hour after restraint stress through rapid decapitation and trunk
blood was collected for assay of corticosterone levels. Plasma
corticosterone was assayed using an RIA kit (MP Biomedicals) and
this assay confirmed elevated levels of corticosterone in stressed
compared to control dams [control: 381.67 ng/ml633.41; stress:
623.33 ng/ml636.02; t(10)=4.92, p,.001].
Tissue Dissection
Feti and placenta were extracted via caesarean section at
gestational Day 20. Pups were decapitated and whole brains
extracted. Placenta and fetal brains were snap-frozen, and stored
at 280C until further processing. Cortex and hypothalamus of
E20 fetal brains were dissected in a cryostat cooled to 220C.
Placenta samples were dissected such that a pie slice including
both the basal zone and inner labyrinth zone was used. Samples
were weighted and homogenized in 700 ml lysis buffer RLT-Plus
(Qiagen) with 0.1% b-mercaptoethanol using a tissue homogenizer
(Omni) for 15–20 seconds. To analyze both mRNA and DNA
methylation from the same sample, RNA and DNA from fetal
cortex, hypothalamus, and placenta samples were isolated
simultaneously using a dual RNA/DNA extraction kit (Qiagen).
cDNA was synthesized using a reverse transcription kit (Applied
Biosystems) according to manufacturer’s protocol. Samples were
stored at 220C until further processing. Subsequent analysis of
gene expression and CpG methylation was conducted using tissue
from 1–2 offspring each of 4 control and 4 stress dams. Selection
was based on average pup weight at the time of sacrifice. Only
litters in which average pup weight was greater than 2.5 g were
included in this sample and average pup weight did not differ
significantly between treatment groups.
Gene Expression Analysis
Tissue (hypothalamus, cortex, placenta) from 2 pups per litter
from 4 control and 4 stress dams were included in the gene
expression analyses. Relative gene expression was measured by
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thermocycler using SybrFast (Applied Biosystems) with standard
amplification and Ct calculation protocols by Applied Biosystems.
All primers were designed to span exons and were tested for
specificity (single melt curve peak) and efficiency (87–105%).
Primer pairs are included in Table 1. Calculations of relative gene
expression of 11b-hydroxysteroid dehydrogenase type 2
(HSD11B2), 11b-hydroxysteroid dehydrogenase -1 (HSD11B1),
DNA methyltransferase-1 (DNMT1), and DNA methyltransferase-
3a (DNMT3a) were conducted with the 2ddCT method [44] using
cyclophilin-A and beta-actin as reference genes. Relative expres-
sion was normalized to control (non-stress) cortex samples.
DNA Methylation Analysis
Tissue (hypothalamus, cortex, placenta) samples from 1 pup per
litter from control and stress dams were run in duplicate and
included in the DNA methylation analyses. Purified DNA was
analyzed (EpigenDX) for CpG methylation by bisulfite pyrose-
quencing. Samples were bisulfite converted and PCR amplified
(see Table 2 for primers). PyroMark reagents (Qiagen) were used
to prepare samples for pyrosequencing (PSQ
TM96HS). 38 CpG
sites in the Rattus norvegicus HSD11B2 gene (see Figure 1) were
assayed (2378 to +56, NC_005118.2, ENSRNOT00000023130).
The region was assayed by two sets of pyrosequencing primers (see
Table 2). Paired samples t-test indicated no significant differences
between duplicates and average level of methylation across
duplicates was used for all subsequent analyses.
Sex Determination
In order to determine the sex of pups, DNA purified from
placenta of each pup was amplified using primers for SRY
(AY157669.1; forward: GGAGAGAGGCGCAAGTT GGCT,
reverse: GCTATGGTGCAGGGTCGGTCA). 50 ng of DNA
was amplified using a PCR amplification kit (Qiagen) according to
standardized protocol (15 min at 95C followed by 35 cycles of 94C
for 30 s, 60C for 30 s, 72C for 30 s, followed by a single hold at
72C for 10 min) with Sybr DNA loading dye. Immediately after
amplification samples were run on a 2% gel and imaged under UV
light. Lanes expressing a bright band were identified as male.
Multiple SRY loci have been identified in the rat genome [45] and
some variability in amplified nucleotide length was observed
around the expected fragment length of 518 bp.
Statistics
All statistics were performed using SPSS (IBM, Version 19).
Analysis of average ddCT levels to determine differences in
gene expression was conducted with a 2-way ANOVA with
tissue type and stress treatment as factors. Tukey’s HSD post-
hoc tests were used to compare tissue-specific gene expression
levels and two-tailed Student’s t-tests were used to determine
significant differences associated with maternal stress. Correla-
tion between DNA methylation levels at specific CpG sites was
conducted with two-tailed Pearson correlation coefficients. One-
way ANOVA was used to compare DNA methylation between
tissue types. Repeated measures ANOVA was used to determine
the impact of maternal stress on DNA methylation and Tukey’s
HSD was used to compare stress effects at specific CpG sites.
Analysis of stress effects on overall levels of DNA methylation
averaged across sites was conducted using two-tailed Student’s t-
tests. Though sex-specific effects on gene expression and DNA
methylation were not observed in this sample, sex was used as
a covariate in the analyses. Significance was set at the p,0.05
level.
Results
Gene Expression in Fetal Hypothalamus, Cortex, and
Placenta
Analysis of HSD11B2 gene expression indicated a main effect
of tissue (F(2,40)=15.37, p,.001), a main effect of stress
(F(1,40)=5.46, p,.05), and a significant tissue by stress
interaction (F(2,40)=6.66, p,.01). Overall, there were signifi-
cantly higher levels of HSD11B2 mRNA in the placenta (p,.01)
compared to fetal hypothalamus and cortex (placenta:
M=28.5767.38; hypothalamus: M=5.856.77; cortex:
M=1.136.17). Prenatal stress was associated with a significant
decrease in HSD11B2 mRNA in the placenta (compared to
controls, p,.05; Figure 2a) and no group differences in
HSD11B2 mRNA were evident in the fetal hypothalamus or
cortex. The stress-induced down-regulation of placental 11b-
HSD was specific to HSD11B2 as analysis of HSD11B1 mRNA
levels indicated no significant effects of stress and no stress by
tissue type interactions on the expression of this gene. Based on
the tissue-specific effects of stress on HSD11B2 gene expression,
we proceeded to determine whether there were tissue specific
effects of stress on the expression of genes involved in epigenetic
regulation of gene expression (DNMT1 and DNMT3a). Overall,
levels of DNMT1 mRNA were found to be significantly higher
in the placenta compared the fetal hypothalamus and cortex
(p,.001) and levels of DNMT3a mRNA were significantly
elevated in the hypothalamus compared to the cortex and
placenta (p,.001; see Figure 2). Within the hypothalamus, we
found a trend for increases in DNMT1 gene expression amongst
prenatally stressed offspring (t(14)=21.79, p=.09). Within the
fetal cortex, DNMT1 expression was significantly increased in
Table 1. Rat RT-PCR primers used in gene expression analyses.
Gene Gene ID Primers
Hydroxysteroid dehydrogenase
(HSD11B2)
NM_017081.1 forward: TGGCAGCCCAGCAGGAGACAT reverse: GCAGCAGTTGCTTGCGCTTCT
Hydroxysteroid dehydrogenase
(HSD11B1)
NM_017080.2 forward: GGGGCCAGCAAAGGGATCGG reverse: AGGCAGCGAGACACCACCTTCT
DNA methyltransferase (DNMT1) NM_053354.3 forward: GTGGGATGGCTTCTTCAGTA reverse: GGCTTGGTCACAAAACAAAC
DNA methyltransferase (DNMT3a) NM_001003958.1 forward: GGGGCCCCAGCTGAAGGAGA reverse: GCCCCGGGAGCCCTCCATTT
Beta-actin NM_031144 forward: ATGGATGACGATATCGCTGCG reverse: GGTGACAATGCCGTGTTCAAT
Cyclophillin-A NM_017101 forward: ATGGTCAACCCCACCGTGTTCTTC reverse: ATCCTTTCTCCCCAGTGCTCAGAG
doi:10.1371/journal.pone.0039791.t001
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were no significant effects of stress on DNMT1 expression in the
placenta. Analysis of the de novo methyltransferase DNMT3a,
indicated a placenta-specific effect of stress on the expression of
this enzyme. Prenatal stress was found to be associated with
increased placental DNMT3a mRNA levels (t(14)=23.71,
p,.01; Figure 2c).
Comparison of CpG Methylation of the HSD11B2 Gene in
Fetal Hypothalamus, Cortex, and Placenta
The HSD11B2 promoter and region from 2378 to +56 is
rich in CpG sites and contains several transcription factor
binding sites for Sp1 and NF-kB, suggesting that this region
would be a likely candidate for regulation of gene transcription
by DNA methylation. Moreover, previous studies in rats report
environmentally-induced differences in methylation within this
region associated with variation in gene transcription [41].
Analysis of within-individual variation in CpG methylation of
the HSD11B2 promoter (and at sites within the first exon – see
Figure 1) generally indicated a lack of correlation in the
methylation status of sites between different tissues. However, at
sites 12 (r(8)=.81, p,.01), 34 (r(8)=.81, p,.01), and 36
(r(8)=.72, p,.05), placental CpG methylation levels were
strongly positively associated with fetal cortex CpG methylation
levels, but neither placenta nor fetal cortex CpG methylation
levels correlated with hypothalamic CpG methylation levels at
these sites. Comparison of average CpG methylation levels at
specific sites within the HSD11B2 promoter across tissue types
indicated several sites that where differentially methylated
between the hypothalamus, cortex, and/or placenta (Table 3).
At sites 1 and 3 (site 1: F(2,23)=114.56, p,.001; site 3:
F(2,23)=8.20, p,.01), there was elevated methylation in
placenta compared to both hypothalamus and cortex (p,.01).
At site 5 (F(2,23)=7.61, p,.01), there was elevated methylation
in placenta and hypothalamus compared to cortex (p,.05). At
sites 10 and 14 (site 10: F(2,23)=4.15, p,.05; site 14:
F(2,23)=8.01, p,.01), there were elevated levels of methylation
in hypothalamus compared to cortex (p,.05). At all other CpG
sites, there were no differences between tissue types in the
average level of DNA methylation.
Impact of Prenatal Stress on HSD11B2 CpG Methylation
Analysis indicated main effects of tissue [F(2,17)=4.67,
p,.05], stress [F(1,17)=4.54, p,.05], and a significant tissue
by stress interaction [F(2,17)=7.76, p,.01] on CpG methyla-
tion within the HSD11B2 promoter. Within the fetal hypothal-
amus (Figure 3a), prenatal maternal stress was associated with
reduced CpG methylation at sites 2, 3, 4, 6, 7, 8, 15, and 33
and elevated CpG methylation at sites 21 and 22. Within the
fetal cortex (Figure 3b), there was no effect of prenatal
maternal stress on CpG methylation. In the placenta
(Figure 3c), prenatal maternal stress was associated with
increased CpG methylation at sites 4, 5, 7, 8, and 15. Stress-
induced changes in hypothalamic and placental CpG methyl-
ation of the HSD11B2 promoter were most evident when
examining CpG site-specific DNA methylation, though analysis
of the effects of stress on average methylation across the
15 CpG sites within the promoter region indicated a trend for
decreased methylation in the hypothalamus (M6SEM; control:
12.26%61.75, stress: 7.66%61.05; p=.06) and increased
methylation within the placenta (control: 9.47%6.53, stress:
12.15%61.00; p=.06).
Table 2. HSD11B2 Bisulfite Pyrosequencing Primers.
Assay Primers
PCR Primers (assay 1) forward: AGGTTTATAGGAGTGAATGAGATG reverse: AACTTTCCTCCACTTCTATCTCAA
PCR Primers (assay 2) forward: GTTGAGATAGAAGTGGAGGAA reverse: CAAATCTAAACCCAACAACTACA
Sequencing Primers (assay 1) 59TATAGGAGTGAATGAGATGT3’ 59GTGTAGTAATTTGGGGA3’
Sequencing Primers (assay 2) 59TGAGATAGAAGTGGAGGAAA3’ 59GAGGGTTTAGTAAAGAAA3’ 59ATTTAGTGTTTTGGTCTAGAG3’
doi:10.1371/journal.pone.0039791.t002
Figure 1. Gene schematic of HSD11B2 and CpG sites analyzed. The rat HSD11B2 gene contains a promoter and five exons. The promoter
(lowercase letters) and first part of exon 1 (capital letters) are indicated and the ATG site is bolded. 38 CpG sites from 2378 to +56 were analyzed for
methylation levels and are indicated in bold and numbered.
doi:10.1371/journal.pone.0039791.g001
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In the current study we report a robust and tissue-specific effect
of maternal stress during pregnancy in rats on mRNA levels of the
enzyme HSD11B2. Stress, anxiety, and depression during preg-
nancy can have a long-lasting impact on the psychological health
of children [4,46]. Chronic unpredictable prenatal stress in rodents
has been shown to impact cognitive and stress-coping behaviors,
particularly when stress is experienced in the third gestational
week [47]. The confinement stress employed in the current study
was mild but daily and unpredictable over the third gestational
week in order to mimic the characteristics of chronic mild stress/
anxiety experienced by human mothers. Consistent with previous
findings, chronic stress was associated with decreased transcription
of HSD11B2 within the placenta in late gestation [12,26].
Maternal stress was also found to induce increases in the
transcription of the DNA methyltransferases DNMT1 and
DNMT3a. Within the placenta, this stress effect was specific to
the de novo methyltransferase DNMT3a, whereas in fetal hypothal-
amus and cortex, prenatal stress induced increased mRNA levels
of DNMT1. Consistent with the reduced HSD11B2 mRNA in
placenta, we find increased placental CpG methylation within
several sites of the HSD11B2 gene promoter associated with
maternal stress. In contrast, our analysis indicates decreased DNA
methylation at several sites of the HSD11B2 gene promoter in fetal
hypothalamic tissue associated with stress and no effect of this
prenatal exposure on DNA methylation in the fetal cortex. These
findings highlight the tissue specificity of epigenetic effects.
However, we do identify several CpG sites within the placenta
at which an individual’s DNA methylation levels do significantly
predict those observed in the fetal cortex, raising the intriguing
possibility of using the epigenetic status of placenta to predict
corresponding changes in the brain. Overall, these findings
provide novel evidence for the epigenetic regulation of HSD11B2
as a potential mechanism linking maternal stress during gestation,
dysregulation of placental gene expression, and neurodevelop-
mental outcomes in offspring.
Though placental 11ß-HSD2 can function as an enzymatic
buffer against the deleterious effects of exposure to maternal
glucocorticoids, it is clear that this enzyme can be down-regulated
by adverse prenatal experiences [26,28,29,48], thus limiting its
capacity to protect the developing fetus. However, the nature and
Figure 2. Tissue-specific expression of HSD11B2 and DNMTs in
offspring exposed to prenatal stress. Average (mean 6 SEM)
mRNA levels of (A) HSD11B2,( B )DNMT1,a n d( C )DNMT3a in
hypothalamus (HYPO), cortex, and placenta in control offspring and
offspring exposed to prenatal stress. Relative gene expression levels
were determined by the 2ddCT method using cyclophilin-A and beta-
actin as internal standards. Relative expression was normalized to
control (non-stress) cortex samples. (n=8/group; { p,0.1; *p,0.05,
**p,0.01).
doi:10.1371/journal.pone.0039791.g002
Table 3. Tissue-specific differences in % CpG methylation
within the HSD11B2 gene promoter.
CpG Site Hypothalamus Cortex Placenta
1 2.216.24 2.346.78 14.826.84**
3 2.586.46 2.466.30 4.276.29**
5 2.786.59 0.966.33* 3.786.59
10 3.546.13* 2.286.33 2.936.40
14 5.576.28* 3.846.39 4.566.23
*p,.05, **p,.01.
doi:10.1371/journal.pone.0039791.t003
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DNA methylation at 38 CpG sites in the HSD11B2 promoter and exon 1 in (A) fetal hypothalamus, (B) fetal cortex, and (C) placenta of control offspring
and offspring exposed to prenatal stress. Location of Sp1 and NF-kB transcription factor binding sites indicated, as well as the transcription start site
(TSS) and ATG start codon. (n=4/group run in duplicate; *p,0.05).
doi:10.1371/journal.pone.0039791.g003
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predicting the direction of the effects on 11ß-HSD2. For example,
acute stress in pregnant rats has been found to increase the activity
of placental 11ß-HSD2 [48] and similarly in humans, betametha-
sone treatment within 72 hours of parturition leads to increased
11ß-HSD2 enzymatic activity [49]. Up-regulation of placental
11ß-HSD2 may thus be an adaptive response to elevated maternal
glucocorticoids. In contrast, chronic exposure to maternal
glucocorticoids may lead to reduced placental 11ß-HSD2, in-
creased exposure of fetal tissues to glucocorticoids, and neurode-
velopmental and metabolic phenotypes associated with glucocor-
ticoid programming. Heightened glucocorticoid exposure during
fetal development may promote lung development and thus
increase survival following pre-term birth – an obstetric outcome
predicted by maternal stress [50,51]. Thus, though heightened
anxiety and HPA activity may be considered maladaptive, these
outcomes may be the cost of promoting survival amongst the
offspring of gestationally stressed females. One possible strategy to
buffer the brain against these neurodevelopmental consequences
would be to increase 11ß-HSD2 within the brain. Though we do
not find an increase in hypothalamic or cortical HSD11B2 mRNA
levels, the stress-induced DNA hypomethylation of this gene that
we observe in hypothalamic tissue may be an epigenetic precursor
to these buffering effects. Time course analysis of HSD11B2 gene
expression and DNA methylation throughout the prenatal stress
exposure and into the postnatal period may thus be a key strategy
for determining the dynamics of glucocorticoid programming
mechanisms.
Investigation of the epigenetic regulation of HSD11B2 has
previously been explored outside the context of studies on
maternal stress. In humans and in rats, the promoter and first
exon of the HSD11B2 gene (regions analyzed in the current study)
are rich in CpG sites and DNA methylation levels at CpG sites
within this region are related to the expression of this gene [52].
Pharmacological hypomethylation of HSD11B2 through in vitro or
in vivo treatment with the DNA methyltransferase inhibitor 5-aza-
29-deoxycytidine has been found to increase HSD11B2 expression
[52]. One functional consequence of elevated DNA methylation is
the inhibition of transcription factor binding to the promoter
regions of target genes and in the case of HSD11B2, CpG
methylation at Sp1 and NF1 recognition sequences prevents
binding of these transcription factors and diminishes the
transcriptional activity of HSD11B2 [52]. Increased hepatic
HSD11B2 promoter methylation and decreased HSD11B2 mRNA
has also been observed in neonatal offspring exposed to in utero
magnesium deficiency [53]. In rats, intrauterine growth restriction
is associated with both reduced HSD11B2 expression and in-
creased HSD11B2 promoter methylation in kidneys at birth and
these epigenetic effects lead to altered transcription factor binding
of Sp1 and NF-kB [41]. These epigenetic effects were found to be
sex-specific and present both at birth and postnatal day 21,
indicating long-term consequences of prenatal HSD11B2 dysre-
gulation. The sex-specificity of environmentally induced changes
in DNA methylation is increasingly evident and indeed epigenetic
modifications may be involved in the normal process of sexual
differentiation [9,54,55]. Though we do not find sex-specific
effects of maternal stress on HSD11B2 expression or DNA
methylation in the current study, it may be that large samples
are needed to detect sex-differences in the epigenetic regulation of
this gene (to account for individual differences in hormonal
exposure) or that sex-differences are more likely to emerge in later
development.
A candidate mechanism for the increased placental DNA
methylation and increased HSD11B2 levels we have found in
response to maternal stress during pregnancy may involve the up-
regulation of DNA methyltransferase levels in the placenta of
stressed offspring. Our data indicate a placenta-specific increase in
DNMT3a mRNA in response to maternal stress. This stress-
induced effect has implications for genome-wide epigenetic
changes, and may account for the diverse phenotypic outcomes
associated with maternal adversity during pregnancy. DNMT1
and DNMT3a are enzymes active throughout the lifespan and
thus could potentially serve as a mechanism for long-term
epigenetic regulation, though it is possible that DNMT3b (only
active early in development) is similarly altered by prenatal stress
to mediate HSD11B2 promoter methylation. Our data are
consistent with previous findings indicating an up-regulation of
DNMTs in the placenta of mice exposed to 1
st trimester maternal
stress [9]. Targeted deletion of DNMT1 or DNMT3a in mice has
been found to produce embryonic and postnatal lethality and
widespread epigenetic changes – particularly amongst imprinted
genes – in embryonic tissues [56–58]. Amongst offspring that are
heterozygous for a mutation in DNA methyltransferase 3-like
(DNMT3L) protein, there are specific disruptions to placental
development [59]. DNMT3L interacts directly with DNMT3a to
facilitate DNA methylation [60], and within the placenta,
epigenetic regulation of DNMTs and DNMT3L may account for
the changing epigenetic and transcriptional profiles in this tissue
during the course of pregnancy [61].
Within the fetal hypothalamus and cortex we observe discor-
dance in the relationship between HSD11B2 mRNA, DNMT
expression, and CpG methylation within the HSD11B2 gene
promoter. Despite stress induced decreases in HSD11B2 CpG
methylation in the fetal hypothalamus, we do not find differential
expression of hypothalamic HSD11B2 and within the fetal cortex
we find stress-induced increases in DNMT1 without corresponding
changes in the DNA methylation or expression of HSD11B2. The
regulation of HSD11B2 expression is complex and these paradox-
ical findings suggest that gene regulation in response to prenatal
stress is also accomplished by other epigenetic mechanisms, such
as chromatin remodeling, as well as regulation by transcription
factors known to influence HSD11B2 transcription (such as Sp1
and NF-kB, see Figure 3). These results illustrate the challenge of
in vivo studies of epigenetic effects and the complexity of the
pathways through which transcriptional activation is achieved.
Determining the temporal dynamics of stress-induced changes in
DNMTs, DNA methylation, and gene expression in different
tissue types may provide some insight into this complexity. For
example, elevations in DNMT3a and DNMT1 will likely precede
elevated methylation of target genes, and the reduced fetal CpG
methylation observed in hypothalamic tissue of stressed offspring
will likely precede observable changes in mRNA in this brain
region. The association of DNMT3a with de novo methylation and
of DNMT1 with maintaining methylation marks in dividing cells
adds a further layer of temporal complexity. Though in vivo
imaging of these changes within individuals is not methodologi-
cally feasible, a cross-sectional design including offspring of
varying embryonic and postnatal ages would help elucidate these
dynamics. In addition, it is important to consider the diversity of
epigenetic mechanisms that can contribute to maternal stress
effects on gene regulation, particularly histone modifications, and
to further explore other physiological factors that have been
demonstrated to alter 1HSD11B2 activity and expression, such as
catecholamines [62] and proinflammatory cytokines [63].
The translation of in vitro and animal studies of environmentally-
induced epigenetic variation in target genes may provide critical
insights into the role of these mechanisms in long-term disease risk.
In humans, maternal antenatal depression has been found to
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39791predict elevations in DNA methylation of the glucocorticoid
receptor gene (NR3C1) promoter in fetal cord blood samples and
the degree of CpG methylation detected in these cells predicts
salivary cortisol levels of infants at 3 three months of age [64].
Maternal stress in the form of intimate partner violence has
similarly been found to predict NR3C1 DNA methylation in blood
samples from children/adolescents that were in utero during the
stressor [65]. In both cases, these studies have used peripheral
tissues as a proxy for potential epigenetic changes that may be
induced within the brain and account for elevations in the HPA
response to stress associated with these adverse prenatal exposures.
However, it is important to note that the relationship between
epigenetic variation in peripheral/available tissues (e.g. blood,
placenta) and target tissues (e.g. brain, organs) has yet to be
established and will likely vary dependent on the target gene, the
nature of the environmental exposure, and the timing of sampling.
Our data indicate that though at most CpG sites within the
HSD11B2 gene promoter, DNA methylation levels are equivalent
across placenta, hypothalamus, and cortex, within-individual
correspondence in the methylation patterns between these tissues
is limited. Though it may be possible to predict brain DNA
methylation from the degree of CpG methylation observed in
placenta – the biological relevance of the epigenetic markers
identified in the current study has yet to be established. Future
studies are needed both in humans and animals to address the
issue of tissue specificity in environmentally-induced epigenetic
variation and to elucidate the mechanisms contributing to the
concordance and discordance in tissue-specific epigenetic profiles.
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